Bringing Disruptive Innovation to Healthcare

Products | STEDICAL SCIENTIFIC

A Biosynthetic Matrix (BSM) Technology


PermeaDerm® Biosynthetic Wound Matrix

Revolutionizing wound management for chronic wounds & burns

 

A Biosynthetic Matrix (BSM) Technology

Epidermal Analogue

 

Dermal Analogue

Enhanced Clinical Outcome

Improved healing environment 

Effective wound closure

Diminished pain

Lower scar formation*

* Clinical Study Data on File

Innovative Product PermeaDerm®

Ultrathin

Transparent

Excellent physical attributes (flexibility, compliance, strength, stretchability, stability)

Easy to secure

Excellent shelf life

Improved User Experience

Effective adherence

Proliferation acceleration

Wound barrier & nerve protection

Single application (superficial wounds)

Visualization of wound healing


Mode of Action - R.A.S.E

Reconstruction of Skin Barrier & ECM

Prevents contamination and protects inner vessels & nerves. Monitors and maintains moisture balance. Provides extracellular matrix environment.

Primary Adherence

Analogue ECM (bio-components) achieved within 5hrs. allowing interaction with fibrin to form a clot within the micro-support system.

Secondary Adherence

3D structure achieved within 72 hours facilitating cell migration, proliferation, and ingrowth.

Epithelialization

Re-epithelialization was achieved, and the wound healed.

 

Indications

PermeaDerm® Gloves

PermeaDerm®

Partial thickness burns wounds and other partial thickness wounds

Donor sites

coverage of meshed autograft

Debrided partial thickness hand burns

Case 1: Deep Partial-thickness Burn (Lower Extremity)

Day 0

Day 8

Day 15, healed

6 mos

Case 2: Deep Partial-thickness Hand Burn

Day 0

Day 0, applicaiton

Week 1, healed

Week 3

Week 7

 

Order Information